Medistim ASA
Medistim ASA (0OCD.L) Stock Overview
Explore Medistim ASA’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4.2B
P/E Ratio
40.57
EPS (TTM)
$5.08
ROE
0.25%
0OCD.L Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Medistim ASA (0OCD.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 64.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $172.64.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 40.57 and a market capitalization of 4.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.